Home Sauvie

Sauvie

In operation
-
Developer of Immuno-Oncology Therapies
Basic
Enterprise Profile

Basic Information

Sauvie Inc. is a biopharmaceutical company founded by UnionVille Capital LLC in 2022, focusing on the development and commercialization of immuno-oncology therapies that are crucial for cancer patients. The company plans to continuously expand key cancer therapies through strategic acquisitions, collaborations, research and development, and commercialization, thereby creating substantial value.
Sauvie Inc.
Delaware,United States of America
unclear
January 01, 2022
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Immunological Techniques
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs